Date	Name	Title	Type	Shares Traded	Price Range
Aug 11, 2011	crowley john f	Officer	Buy	10,000	4.20
Mar 7, 2012	barrett m james	Director	Buy	925,154	5.70
Mar 7, 2012	barris peter j	Beneficial Owner (10% or more)	Buy	1,140,000	5.70
Mar 7, 2012	kramlich c richard	Beneficial Owner (10% or more)	Buy	1,140,000	5.70
Mar 7, 2012	new enterprise associates 11 lp	Beneficial Owner (10% or more)	Buy	925,154	5.70
Mar 7, 2012	newhall charles w iii	Beneficial Owner (10% or more)	Buy	1,140,000	5.70
Mar 7, 2012	perry mark w	Beneficial Owner (10% or more)	Buy	1,140,000	5.70
Mar 30, 2012	crowley john f	Officer	Option Execute	49,931	0.64
Jul 17, 2012	glaxosmithkline plc	Beneficial Owner (10% or more)	Buy	2,949,581	6.30
Nov 13, 2012	winterbottom joan	Officer	Buy	1,665	4.54
Mar 15, 2013	barer sol j	Director	Buy	25,000	3.40
Mar 15, 2013	crowley john f	Officer	Acquisition (Non Open Market)	18,506	3.49
Showing 381-392 of 392 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  See Previous 20

Stock transaction information provided by EDGAR Online. Amicus Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.